About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker DBD

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Jul 31, 2026Thomas S. Timko
EVP, CFO
DBD
Diebold Nixdorf Incorporated
Buy700$72.29$50.6K BuyForm 4 ↗
Jun 26, 2026Brian D. Connolly
10% owner
DBD
Diebold Nixdorf Incorporated
Sale100,000$84.80$8.5M SaleForm 4 ↗
Jun 25, 2026Brian D. Connolly
10% owner
DBD
Diebold Nixdorf Incorporated
Sale2,741$85.06$233.1K SaleForm 4 ↗
Jun 24, 2026Brian D. Connolly
10% owner
DBD
Diebold Nixdorf Incorporated
Sale228,723$83.95$19.2M SaleForm 4 ↗
Jun 15, 2026Brian D. Connolly
10% owner
DBD
Diebold Nixdorf Incorporated
Sale1,765$83.91$148.1K SaleForm 4 ↗
Jun 12, 2026Brian D. Connolly
10% owner
DBD
Diebold Nixdorf Incorporated
Sale159,675$82.12$13.1M SaleForm 4 ↗
Jun 11, 2026Millstreet Capital Management LLC
10% owner
DBD
Diebold Nixdorf Incorporated
Sale1,108$82.06$90.9K SaleForm 4 ↗
Jun 10, 2026Millstreet Capital Management LLC
10% owner
DBD
Diebold Nixdorf Incorporated
Sale17,660$82.08$1.4M SaleForm 4 ↗
Jun 8, 2026Brian D. Connolly
10% owner
DBD
Diebold Nixdorf Incorporated
Sale88,334$82.99$7.3M SaleForm 4 ↗
May 27, 2026Octavio Marquez
President and CEO, Director
DBD
Diebold Nixdorf Incorporated
Buy621$79.56$49.4K BuyForm 4 ↗
May 26, 2026Octavio Marquez
President and CEO, Director
DBD
Diebold Nixdorf Incorporated
Buy629$79.37$49.9K BuyForm 4 ↗
May 22, 2026Jonathan Myers
EVP, Chief Revenue Officer
DBD
Diebold Nixdorf Incorporated
Buy1,360$73.41$99.8K BuyForm 4 ↗
May 22, 2026Thomas S. Timko
EVP, CFO
DBD
Diebold Nixdorf Incorporated
Buy672$74.36$50.0K BuyForm 4 ↗
Apr 16, 2026Craig Kelleher
10% owner
DBD
Diebold Nixdorf Incorporated
Sale60,833$84.77$5.2M SaleForm 4 ↗
Apr 15, 2026Craig Kelleher
10% owner
DBD
Diebold Nixdorf Incorporated
Sale51,472$85.43$4.4M SaleForm 4 ↗
Apr 8, 2026Millstreet Capital Management LLC
10% owner
DBD
Diebold Nixdorf Incorporated
Sale399,929$82.42$33.0M SaleForm 4 ↗
Jan 15, 2026Craig Kelleher
10% owner
DBD
Diebold Nixdorf Incorporated
Sale500,000$68.00$34.0M SaleForm 4 ↗
Nov 6, 2025Craig Kelleher
10% owner
DBD
Diebold Nixdorf Incorporated
Sale40,522$64.52$2.6M SaleForm 4 ↗
Nov 5, 2025Craig Kelleher
10% owner
DBD
Diebold Nixdorf Incorporated
Sale211,204$62.93$13.3M SaleForm 4 ↗
Sep 18, 2025Millstreet Capital Management LLC
10% owner
DBD
Diebold Nixdorf Incorporated
Sale38,963$60.08$2.3M SaleForm 4 ↗
Sep 16, 2025Millstreet Capital Management LLC
10% owner
DBD
Diebold Nixdorf Incorporated
Sale20,000$60.11$1.2M SaleForm 4 ↗
May 9, 2025Frank Tobias Baur
EVP of Operational Excellence
DBD
Diebold Nixdorf Incorporated
Buy700$46.12$32.3K BuyForm 4 ↗
Feb 28, 2025Emanuel R. Pearlman
Director
DBD
Diebold Nixdorf Incorporated
Sale1,000$43.65$43.6K SaleForm 4 ↗
Feb 28, 2025Emanuel R. Pearlman
Director
DBD
Diebold Nixdorf Incorporated
Sale1,000$43.71$43.7K SaleForm 4 ↗
Feb 27, 2025Capital World Investors
10% owner
DBD
Diebold Nixdorf Incorporated
Sale19,842$43.65$866.1K SaleForm 4 ↗
Nov 12, 2024Frank Tobias Baur
EVP of Operational Excellence
DBD
Diebold Nixdorf Incorporated
Buy5,310$41.42$219.9K BuyForm 4 ↗
Nov 12, 2024Thomas S. Timko
EVP, CFO
DBD
Diebold Nixdorf Incorporated
Buy360$40.75$14.7K BuyForm 4 ↗
Nov 12, 2024Octavio Marquez
President and CEO, Director
DBD
Diebold Nixdorf Incorporated
Buy491$40.57$19.9K BuyForm 4 ↗
Nov 12, 2024Octavio Marquez
President and CEO, Director
DBD
Diebold Nixdorf Incorporated
Buy1,199$40.95$49.1K BuyForm 4 ↗

29 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:20 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances